ANI Pharmaceuticals Inc (ANIP)
54.16
-0.05
(-0.09%)
USD |
NASDAQ |
Dec 24, 16:00
ANI Pharmaceuticals Total Assets (Quarterly): 1.287B for Sept. 30, 2024
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Windtree Therapeutics Inc | 30.45M |
| Allogene Therapeutics Inc | 589.12M |
| AIM ImmunoTech Inc | 13.59M |
| Protalix BioTherapeutics Inc | 61.56M |
| Armata Pharmaceuticals Inc | 98.24M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 856.58M |
| Shareholders Equity (Quarterly) | 430.80M |
| Debt to Equity Ratio | 1.452 |
| Current Ratio | 2.745 |
| Net Debt Paydown Yield | -5.40% |